secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERACYTE, INC. (VCYT)
CIK:        0001384101
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001384101-25-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Veracyte Q4 revenue $118.6M (+21%), net income $5.1M vs. loss a year ago
------------------------------------------------------------------------

- Q4 total revenue $118.6M (+21%), testing revenue $112.2M (+24%), testing volume +25% to 39,107 tests.
- Q4 net income $5.1M vs. net loss in Q4 2023; adjusted EBITDA $26.1M (22.0% margin), up 76%.
- Full-year 2024 revenue $445.8M (+23%), net income $24.1M vs. 2023 loss; adj. EBITDA $91.9M (20.6%).
- Decipher revenue +44% in Q4, volume +45% to >22,400 tests; Afirma revenue +4%, volume +8%.
- Cash from operations $75.1M in 2024; ended with $289.4M cash & short-term investments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1384101/000138410125000010/0001384101-25-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1384101/000138410125000010/vcyt-20250224.htm
  HTML page:      https://secwatch.observer/filing/0001384101-25-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer